Highlights
- Sentinel lymph node biopsy (SLNB) in head and neck Merkel cell carcinoma (MCC) demonstrates a sensitivity of only 52.6%, significantly lower than in other cutaneous malignancies.
- The procedure failed in 29.0% of cases, with failure significantly associated with tumor location, female sex, and advanced age.
- Lymphovascular invasion (LVI), infiltrative growth patterns, and tumor size are the strongest predictors of occult nodal disease.
- Negative or failed SLNB results in this region may require intensified surveillance or adjuvant therapy due to a false-negative rate of 26.7%.
Background: The Challenge of Merkel Cell Carcinoma in the Head and Neck
Merkel cell carcinoma (MCC) is a rare but highly aggressive neuroendocrine malignant neoplasm of the skin. While it accounts for a small fraction of skin cancers, its mortality rate exceeds that of melanoma. Approximately one-third of all MCC cases occur in the head and neck region, an area characterized by a dense and complex lymphatic network. The management of the clinically node-negative (cN0) neck remains one of the most debated topics in head and neck oncology.
Sentinel lymph node biopsy (SLNB) has long been the gold standard for nodal staging in various cutaneous malignancies, including melanoma and MCC of the extremities. The rationale is that the status of the first draining lymph node—the sentinel node—reflects the status of the entire nodal basin. However, the head and neck present unique anatomical challenges, including overlapping drainage basins and the proximity of vital structures. Until recently, the specific accuracy of SLNB for head and neck MCC remained poorly defined, leading to uncertainty in clinical decision-making and risk stratification.
Study Design and Methodology
To address this knowledge gap, Wang and colleagues conducted a robust single-center cohort study at a high-volume academic institution. The study analyzed patients with clinically node-negative head and neck MCC who underwent SLNB between January 2006 and January 2025. This long-term follow-up (median 1.9 years, with some patients followed for nearly 5 years) provided a comprehensive dataset for evaluating nodal recurrence and procedural success.
The primary objectives were to determine the sensitivity, negative predictive value (NPV), and false-negative (FN) rate of SLNB in this specific anatomical region. Furthermore, the researchers sought to identify factors associated with SLNB failure—defined as the inability to visualize the node on lymphoscintigraphy, failure to identify it intraoperatively, or the absence of nodal tissue in the final pathology—and factors predictive of actual nodal disease using Cox proportional hazards models.
Analysis of Results: A Critical Look at Diagnostic Accuracy
The study included 86 participants with a mean age of 75.6 years. Of these, 69 patients (80.2%) proceeded to SLNB. The findings provide a sobering perspective on the limitations of the procedure in the head and neck region.
Sentinel Lymph Node Biopsy Success and Failure Rates
Perhaps the most striking finding was the high failure rate of the procedure itself. SLNB failed in 29.0% (20 of 69) of the patients. This is considerably higher than failure rates typically reported for MCC in other body sites. Analysis revealed that tumor location within the complex folds of the head and neck, female sex, and older age were associated with a higher likelihood of procedural failure. These failures represent a significant clinical dilemma: if a sentinel node cannot be identified, the clinician is left without definitive staging information for a disease known for rapid regional spread.
Sensitivity and Predictive Value
For those who successfully underwent the procedure, occult nodal disease was identified in 27.5% of cases. However, the sensitivity of the test was only 52.6%. In clinical terms, this means that the SLNB failed to identify nearly half of the patients who actually had nodal disease. The negative predictive value was 88.6%, and the false-negative rate was 26.7%. These statistics suggest that a negative SLNB in the head and neck does not offer the same degree of reassurance as it might in a patient with a primary tumor on the trunk or leg.
Risk Factors for Nodal Metastasis
The researchers identified three primary histopathological and clinical features that correlated strongly with the presence of nodal disease: lymphovascular invasion (LVI), an infiltrative growth pattern, and increasing tumor size. Using Cox analysis, these factors were shown to have the largest effect sizes on the development of nodal disease. Patients exhibiting these features were significantly more likely to harbor occult metastases, regardless of the SLNB result.
Clinical Interpretation and Expert Commentary
The results of this study necessitate a shift in how clinicians interpret SLNB in the context of head and neck MCC. The lower sensitivity observed here (52.6%) compared to historical benchmarks for other sites highlights the technical and biological complexity of the region.
The Anatomical Complexity of the Head and Neck
The head and neck contain roughly one-third of the body’s lymph nodes. Drainage patterns are notoriously unpredictable; a lesion on the cheek might drain to the parotid gland, the submandibular space, or directly to the deep cervical chains. This complexity increases the risk of ‘missing’ the true sentinel node, especially if the radioactive tracer or dye bypasses a node or if multiple basins are involved. The high failure rate (29%) further underscores the difficulty of mapping these pathways in an older population where lymphatic flow may be altered by age-related changes or previous actinic damage.
Biological Aggression and Growth Patterns
The association of infiltrative growth patterns and LVI with nodal disease reinforces the biological profile of MCC as a neuroendocrine tumor with high metastatic potential. In patients where these features are present, the clinical suspicion for nodal involvement should remain high, even in the face of a negative SLNB. The findings suggest that the microscopic behavior of the tumor may be a more reliable indicator of risk than the biopsy result alone in certain high-risk subsets.
Conclusion: Toward a Tailored Management Strategy
The study by Wang et al. concludes that while SLNB remains a useful tool for identifying a significant portion of occult nodal disease in head and neck MCC, it is not infallible. The high false-negative rate and frequent procedural failures mean that a ‘negative’ result cannot be the sole determinant of post-operative care.
For patients with a failed SLNB or those with a negative SLNB who possess high-risk features—such as large tumor size, LVI, or infiltrative growth—clinicians should consider more aggressive management. This may include elective neck irradiation (ENI) or intensified clinical and radiographic surveillance. As we move toward a more personalized approach to oncology, integrating these pathological risk factors with surgical findings will be essential to improving outcomes in this challenging patient population.
References
- Wang SY, Turner G, Valdes-Morales KL, et al. Accuracy of Sentinel Lymph Node Biopsy to Predict Nodal Metastasis in Head and Neck Merkel Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery. 2026;152(3):313-322.
- Bichakjian CK, Olencki T, Aasi SZ, et al. Merkel Cell Carcinoma, Version 1.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network.
- Schmults CD, Blitzblau R, Aasi SZ, et al. NCCN Guidelines Insights: Merkel Cell Carcinoma, Version 2.2022. J Natl Compr Canc Netw. 2022;20(10):1064-1073.
